Based on the results of this study, this combinatorial treatment approach controlled COVID-19 by targeting ACE2-dependent virus entry and inhibiting SARS-CoV-2 RNA replication capacity into host cells [91]. This evidence concerns the gene ACE2 and COVID-19.